க்ளேண்மர்க் சிறப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark arm gets Russian Health Ministry nod for nasal spray Ryaltris February 22, 2021 Glenmark Pharmaceuticals on Monday said its Swiss subsidiary has received marketing approval from the Russian health regulator for its nasal spray Ryaltris. Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. The drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. “Glenmark Specialty received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray a novel fixed-dose combination nasal spray. This paves the way for commercialisation of Ryaltris in Russia which is expected to be made available to patients in the country in Q1FY2021-22,” Glenmark Pharmaceuticals said in a regulatory filing.

Russian federationCsaba kantorMinistry of health the russian federationGlenmark pharmaceuticalsGlenmark pharmaceuticals onRyaltris nasal spraySenior vice presidentGlenmark specialtyNasal spray ryaltrisரஷ்ய கூட்டமைப்புஅமைச்சகம் ஆஃப் ஆரோக்கியம் தி ரஷ்ய கூட்டமைப்புக்ளேண்மர்க் மருந்துகள்க்ளேண்மர்க் மருந்துகள் ஆன்மூத்தவர் துணை ப்ரெஸிடெஂட்க்ளேண்மர்க் சிறப்பு